The 55-page handbook, now available in English and soon to be available in Spanish, features sections on prenatal exposure, dysmorphology, neuropsychology, the diagnostic process, and case-based learning modules.
The advance has the potential to eliminate complications that arise from missing doses of life-saving medicines, according to the study published today in Nature Materials, a leading peer-reviewed biomedical research journal.
The Jan. 17 issue of the Journal of the American Medical Association (JAMA) features an important study about sepsis with an accompanying editorial by a University of Nebraska Medical Center expert. The study and editorial sets the record straight on an unproven therapy some physicians use to treat sepsis, a deadly infectious disease.
The editorial, written by Andre Kalil, M.D., M.P.H., professor of infectious diseases in the UNMC Department of Internal Medicine, writes in support of the new and rigorous international study based on a randomized clinical trial in Australia, published in the same issue. The editorial appears in the Jan. 17 online issue and also will appear in the Feb. 4 print edition.
A study published today online in the Journal of the American Medical Association (JAMA) found marijuana use in electronic cigarettes has been increasing among U.S. middle and high school students from 2017 to 2018.
Evaluation shows gene editing has become 10 to 20 times more efficient in past six years in generating complex animal models called conditional knockouts, which ultimately provide greater insight into gene function and disease findings.
UNMC is the only institution in the central plains region participating in the research. Globally, 880 patients will be enrolled at 130 sites in 20 countries. Researchers will follow patients for up to five years.
Courtney Burnette, Ph.D., an international expert in the diagnosis of children with autism spectrum disorders and the early identification of young children at risk for this diagnosis, has been named the director of the Munroe-Meyer Institute’s integrated Center for Autism Spectrum Disorders (iCASD).
There are plenty of evidence-based behavioral health programs aimed at helping children and adolescents, but implementing those programs can often take up to three years and sustaining them can be even more difficult once implemented.
University of Nebraska Medical Center leading national team to determine if ruxolitinib is effective for treating a certain type of graft versus host disease (GVHD) called sclerotic. The grant is funded by Incyte, a global biopharmaceutical company.
A study published this month in the Annals of Internal Medicine found that adults with severe obesity had greater initial and sustained weight loss with gastric bypass surgery compared to sleeve gastrectomy or adjustable gastric banding surgery.
UNMC is hosting the National Modeling & Simulation Coalition 2018 National Meeting, which will be held Sept. 25- 26 in Omaha. The meeting is being co-hosted by the Interprofessional Experiential Center for Enduring Learning (iEXCELSM ) and the National Strategic Research Institute (NSRI). The focus of the interdisciplinary meeting is on “Improving Human Performance and Effectiveness.”
Next year, UNMC will open a new, $121.8 million advanced clinical simulation facility (currently under construction) -- the Dr. Edwin Davis & Dorothy Balbach Davis Global Center for Advanced Interprofessional Learning (Davis Global Center) at 42nd and Emile streets in Omaha. Funded by state and private money, the facility is designed to transform the way health professionals learn new skills and acquire new knowledge.
The way health care providers are paid is shifting, demanding major changes by providers. Instead of being paid for the number of patients they see and tests ordered, the system is moving toward paying providers based on patient satisfaction, good clinical outcomes and cost effectiveness.
Goal is to make University of Nebraska go-to place for biodefense education for students hoping to work for the Department of Defense. Vision is to build an education pipeline that starts at the undergraduate level and continues through the graduate level, providing unique opportunities for brightest students from Nebraska and around the country.
Special report details serious concerns that medical community would be able to do much, if anything, to assist people in event of major nuclear event. Prevention is best option as well as carefully conceived, long-term plan within the public education system to provide lessons on radiation biology
A one-month antibiotic regimen to prevent active tuberculosis (TB) disease was at least as safe and effective as the standard nine-month therapy for people living with HIV, according to results of a large international clinical trial.
Adults and adolescents in the trial were more likely to complete the short-course regimen consisting of daily doses of the antibiotics rifapentine and isoniazid for four weeks than the standard nine-month regimen of daily isoniazid.
A research team has identified the pathological mechanism for a certain type of autism and intellectual disability by creating a genetically modified mouse. They are hopeful it could eventually lead to a therapeutic fix.
Results of a University of Nebraska Medical Center study published in the Oct. 10 issue of PLOS ONE, found if the standard supplementation of 400 IUs of vitamin D is increased to 800 IUs daily there are reductions in the number of premature and preterm babies with extremely low bone density.
A research team at the University of Nebraska Medical Center College of Public Health has determined that a special mixture of good bacteria in the body reduced the incidence of sepsis in infants in India by 40 percent at a cost of only $1 per infant.
A study published May 17 in the journal Genome Biology shows how highly popular custom genetically engineered animal models are easily generated using a new patent-pending technology called Easi-CRISPR.
A study at the University of Nebraska Medical Center (UNMC) found that a novel device can significantly reduce contamination of blood cultures, potentially reducing risky overtreatment and unnecessary use of antibiotics for many patients. This approach could also substantially reduce healthcare costs, according to the study.
Thousands of U.S. patients get their blood drawn every day for blood cultures in order to diagnose serious infections such as sepsis, which can be a deadly condition. A small but significant percentage of the blood cultures are contaminated, due in part to skin fragments containing bacteria that are dislodged during a blood draw.
This leads to false results that can mislead clinicians into thinking a patient has a potentially serious bloodstream infection. The consequences are costly and put patients at risk.
Health care is emerging as one of the largest global virtual and augmented reality markets outside of the video gaming industry. What aviation simulation did for the flight industry, these new technologies will do for health care education in the new center.
The 2018 opening of a new $118.9 million center at the University of Nebraska Medical Center (UNMC) in Omaha will feature the world’s most advanced technology in clinical simulation that will propel health care education into the next generation with virtual and augmented reality.
Her book, which applies beyond toddlerhood, has less to do with the alphabet or numbers and more to do with ME, WE, WHY, WILL, WIGGLE, WOBBLE and WHAT IF. Dr. Jana calls them QI skills, and identifies them as necessary for 21st century success, and their development starts much earlier than most people realize -- in the first five years.
In connecting with business leaders, economists and entrepreneurs, she discovered that the skills most coveted in today’s workforce are the very same as those that are best nurtured in the first five years of life.
Using a process called LASER ART (long-acting slow effective release antiretroviral therapy), a research team has discovered an unexpected pathway to open cell storage areas for antiviral drugs. The discovery could revolutionize current treatments for HIV/AIDS by extending the actions of disease-combating medicines.
The new $35 million home for UNMC’s College of Pharmacy boasts state-of-the-art laboratories and education space equipped with next-generation technology and simulation and experiential-learning tools designed to help prepare future pharmacists for expanded roles in a changing health care landscape.
Sam Sanderson, Ph.D., a research associate professor in the UNMC College of Pharmacy, recently secured an R01 grant from the National Institutes of Health to find a workable solution to the problem of antibiotic resistance.
Red blood cell exchange offers the risk lowering benefit of frequent blood transfusions but does so without increasing the iron stored in the body. Patients are connected to an apheresis machine which removes sickled red cells and replaces them with normal red cells from donors.
Researchers at the University of Nebraska Medical Center and the University of Memphis recently published an article in the American Journal of Men’s Health which found that men and their health providers are not having important discussions when it comes to prostate cancer screening and treatment.
A novel drug candidate can prevent nerve cell damage in a mouse model with Parkinson's disease. The drug protects nerve cells that produce dopamine, the chemical responsible for agility and movement that is lost in Parkinson's.
Study results show that physicians are underutilizing methotrexate, the leading drug for rheumatoid arthritis (RA), or not keeping patients on the drug long enough before switching them to more expensive biologic drug options.
New iPhone app from Apple is designed to make it easier for large numbers of HIV patients to participate in research. Will enable participants to easily complete tasks or submit surveys right from the app.
A new H1N1 vaccine is entering a definitive round of testing this month. Researchers hope to establish its ability to ward off the virus. If tests yield results as expected, hog farmers could begin using the new vaccine as early as the end of the year.
In the last decade, there’s been an explosion in treating PAD using angioplasty and stenting – a minimally invasive procedure in which the patient is awake and usually leaves the hospital the next day.
Stents, small tubular metal devices that doctors put in diseased arteries to keep them open, work well in the heart, but often fail miserably in the leg arteries. Though peripheral artery disease stents may generally work for many patients, there is significant room for improvement as many patients require repeat procedures in as little as one or two years, said Jason MacTaggart, M.D. A national study estimated the cost at $21 billion a year.
Lung cancer patients with comorbid conditions such as chronic obstructive pulmonary disease, diabetes, or congestive heart failure have a higher risk of death than lung cancer patients without comorbid conditions. The prevalence of these comorbidities is higher in older lung cancer patients than patients who are younger. As the population of the United States ages, there will be a higher number of lung cancer patients with comorbidities at diagnosis. An estimated 74 percent of patients have one or more comorbidities. More than 50 percent of those with comorbidities had pulmonary disease, while 16 percent had diabetes, and 13 percent had congestive heart failure.
An innovative training program at the University of Nebraska Medical Center using lightly embalmed cadavers helps better prepare surgeons in training and serves as a national model. Lightly embalmed cadavers more realistically mimic actual surgeries and allow surgeons in training to walk before they run.
Over two and a half years, researchers will develop a formulation of a molecule called Butyrylcholinesterase (BChE) into an intramuscular injection, and prove its safety, effectiveness and dosing in animal models. They also will demonstrate its ability in dried form to retain activity for at least two years, and produce the substance for other research studies.
BChE, which is found in human plasma, is a bioscavenger and when it finds nerve agent in the blood, it deactivates it.
Following successful results, researchers will seek Food and Drug Administration approval followed by commercial production. Once research is complete, making it available for commercial use could take two to four years.